2017 - CIRTA


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

10- Intestinal Transplantation

52.10 - Prevalence of Micronutrient Deficiencies after Adult Intestinal Transplantation

Presenter: Kwai, Lam, New York, United States
Authors: Kwai Lam, Alyssa Burnham, Jang Moon, Thomas Schiano, Kishore Iyer

Prevalence of Micronutrient Deficiencies after Adult Intestinal Transplantation

Kwai Lam1, Alyssa Burnham1, Jang Moon1, Thomas Schiano1, Kishore Iyer1.

1Intestinal Rehabilitation & Transplantatin Program, Mount Sinai Medical Center, New York, NY, United States

Introduction: Achieving enteral autonomy from parenteral nutrition (PN) is the ultimate goal of intestinal transplantation (ITX). While macronutrient absorption is typically adequate post-ITX, the degree of micronutrient absorption is poorly known. In pediatric ITX, micronutrient deficiencies after ITX may be common [1]. More specifically, pyridoxal deficiency after ITX and multi-visceral transplant has been reported [2]. In this study, we report preliminary findings on prevalence and risk factors for micronutrient deficiencies after adult ITX.

Method: Retrospective review of prospectively collected data on micronutrient levels (vitamins (vit) A, E, B6, B12, D 25-OH, zinc, copper, selenium, iron, folate, and ferritin) from a small cohort of patients who had achieved enteral independence after ITX.

Results: Micronutrients: Micronutrient levels were assayed at least once post-transplant and prior to any repletion (7 patients in first post-transplant year, 5 patients after the first year). All patients had at least 1 micronutrient deficiency. One patient had up to 4 different deficiencies (Vit E, D 25-OH, B12, zinc). Deficiencies were observed in all micronutrients, except selenium and folate. The most prevalent deficiency was vit D (n=11), followed by zinc (n= 6), ferritin (n= 5), vit B6 (n= 4), vit B12 (n=2), E (n=2), copper (n= 1) and A (n= 1).

Clinical Complications: Four patients had biopsy-proven acute rejection (severe, n= 2, mild, n= 2). They were treated with steroid (n= 2), thymoglobulin (n= 1), and a combination of steroid, thymoglobulin, plasmapheresis and IVIG (n= 1). Six patients had biopsy-proven non-specific enteritis. Patients with rejection and non-specific enteritis accounted for 90% (29/32) of observed deficiencies. Incidence of micronutrient deficiencies were same (16/32) between patients > 1-year post ITX and <1-year post ITX. Two patients did not have rejection or enteritis; only deficiencies observed in these 2 were vit D (n= 2) and ferritin (n= 1). 

Conclusions: Our preliminary data suggest that, consistent with limited available studies, micronutrient deficiencies are almost universally prevalent after ITX. Selenium and folate deficiencies seem uncommon. Patients with rejection and non-specific enteritis appear to be more likely to have micronutrient deficiencies. The length of time since transplant does not appear to confer adequacy of micronutrient status.

[1] Ubesie AC, Cole CR, Nathan JD, et al. Micronutrient deficiencies in pediatric and young adult intestinal transplant patients. Pediatr Transplant. 2013;17(7):638-645. doi:10.1111/petr.12132.
[2] Matarese LE. Nutrition and fluid optimization for patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2013;37:161-170. doi:10.1177/0148607112469818.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada